Shigella and enteroinvasive Escherichia coli: Paradigms for pathogen evolution and host–parasite interactions - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 232

Jennison, A.V., Verma, N.K., 2007. The acid-resistance pathways of Shigella lexneri 2457T. Micro-
biology 153, 2593-2602 .
Jin, Q., Yuan, Z., Xu, J., et al., 2002. Genome sequence of Shigella lexneri 2a: insights into patho-
genicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids
Res. 30, 4432-4441 .
Kabir, I., Butler, T., Khanam, A., 1986. Comparative eficacies of single intravenous doses of cef-
triaxone and ampicillin for shigellosis in a placebo-controlled trial. Antimicrob. Agents. Che-
mother. 29, 645-648 .
Kane, C.D., Schuch, R., Day Jr., W.A., Maurelli, A.T., 2002. MxiE regulates intracellular expres-
sion of factors secreted by the Shigella lexneri 2a type III secretion system. J. Bacteriol. 184,
4409-4419 .
Kayath, C.A., Hussey, S., El hajjami, N., Nagra, K., Philpott, D., Allaoui, A., 2010. Escape of intra-
cellular Shigella from autophagy requires binding to cholesterol through the type III effector,
IcsB. Microbes. Infect. 12, 956-966 .
Kennedy, F.M., Astbury, J., Needham, J.R., Cheasty, T., 1993. Shigellosis due to occupational con-
tact with non-human primates. Epidemiol. Infect. 110, 247-251 .
Kerneis, S., Guerin, P.J., von Seidlein, L., Legros, D., Grais, R.F., 2009. A look back at an ongoing
problem: Shigella dysenteriae type 1 epidemics in refugee settings in Central Africa (1993-
1995). PLoS One 4, e4494 .
Kim, D.W., Lenzen, G., Page, A.L., Legrain, P., Sansonetti, P.J., Parsot, C., 2005. The Shigella lex-
neri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating
enzymes. Proc. Natl. Acad. Sci. USA 102, 14046-14051 .
Kim, M., Ogawa, M., Fujita, Y., et al., 2009. Bacteria hijack integrin-linked kinase to stabilize focal
adhesions and block cell detachment. Nature 459, 578-582 .
Kinsey, M.D., Formal, S.B., Dammin, G.J., Giannella, R.A., 1976. Fluid and electrolyte transport in
rhesus monkeys challenged intracecally with Shigella lexneri 2a. Infect. Immun. 14, 368-371 .
Kotloff, K.L., Winickoff, J.P., Ivanoff, B., et al., 1999. Global burden of Shigella infections: impli-
cations for vaccine development and implementation of control strategies. Bull. World Health
Organ. 77, 651-666 .
LaBrec, E.H., Schneider, H., Magnani, T.J., Formal, S.B., 1964. Epithelial cell penetration as an
essential step in the pathogenesis of bacillary dysentery. J. Bacteriol. 88, 1503-1518 .
Lan, R., Alles, M.C., Donohoe, K., Martinez, M.B., Reeves, P.R., 2004. Molecular evolutionary rela-
tionships of enteroinvasive Escherichia coli and Shigella spp. Infect. Immun. 72, 5080-5088 .
Lan, R., Lumb, B., Ryan, D., Reeves, P.R., 2001. Molecular evolution of large virulence plasmid in
Shigella clones and enteroinvasive Escherichia coli . Infect. Immun. 69, 6303-6309 .
Le Gall, T., Mavris, M., Martino, M.C., Bernardini, M.L., Denamur, E., Parsot, C., 2005. Analysis
of virulence plasmid gene expression deines three classes of effectors in the type III secretion
system of Shigella lexneri . Microbiology 151, 951-962 .
Levine, M.M., Levine, O.S., 1994. Changes in human ecology and behavior in relation to the emer-
gence of diarrheal diseases, including cholera. Proc. Natl. Acad. Sci. USA 91, 2390-2394 .
Magdalena, J., Hachani, A., Chamekh, M., et al., 2002. Spa32 regulates a switch in substrate speci-
icity of the type III secreton of Shigella lexneri from needle components to Ipa proteins. J.
Bacteriol. 184, 3433-3441 .
Makino, S., Sasakawa, C., Kamata, K., Kurata, T., Yoshikawa, M., 1986. A genetic determinant
required for continuous reinfection of adjacent cells on large plasmid in S. lexneri 2a. Cell 46,
551-555 .
Maurelli, A.T., 2007. Black holes, antivirulence genes, and gene inactivation in the evolution of
bacterial pathogens. FEMS Microbiol. Lett. 267, 1-8 .